Genotype, Early Viral Reduction Best Indicators For Treatment Response.

Publication: Hepatitis Weekly

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2001 NewsRX

2001 APR 23 - (NewsRx.com & NewsRx.net) --

by Sonia Nichols, staff medical writer - Early viral clearance is a key factor for whether or not chronic hepatitis C patients will show a sustained response to interferon/ribavirin therapy.

Hepatitis C virus (HCV) genotype also weighs in on sustained response, according to researchers.

Investigators reporting in the Scandinavian Journal of Infectious Diseases studied viral response to interferon...

Read the full article for free courtesy of your local library.